Aaron Z. Savit, PhD

Associate

Contact

Practice Areas

Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S. International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

Aaron Z. Savit, PhD

Associate

Hartford

Contact

Practice Areas

Download PDF Download V-Card

Prior to joining the firm, Aaron was a tenured professor in Peru, where he oversaw the design and construction of the first genomic sequencing facility in the country. He also supervised the parallel development of a gene bank for large-scale cryogenic preservation of native genetic resources. Aaron’s doctoral research explored within-species genetic variation in the bird genus Tangara, focusing on the influence of biogeography. At the time, he was a research associate at the Field Museum’s Pritzker Laboratory for Molecular Systematics and Evolution.

While in Peru, Aaron obtained funding for an Illumina NextSeq 500 Genomic Sequencer from the Fondo Nacional de Ciencia y Tecnología (FONDECYT). In April 2016, he received an award for the publication of scientific articles from the Consejo Nacional de Ciencia y Tecnología (CONCYTEC) in Peru.

Aaron was a summer associate with Axinn in 2019. He graduated with honors from Emory University. Aaron earned his PhD and MS from the University of Chicago. There, Aaron received a Graduate Research Fellowship from the National Science Foundation for three years beginning in March 2008. He was also awarded a Hinds Fund Research Grant from The University of Chicago in June 2008. He holds a BA in Biology from Earlham College.

Education

JD, with Honors – Emory University School of Law (2020)
PhD, Committee on Evolutionary Biology – The University of Chicago (2014)
MS, Committee on Evolutionary Biology – The University of Chicago (2009)
BA – Earlham College (2007)

Admissions

Connecticut
U.S. District Court District of Connecticut

Quotes

Axinn's team is always responsive and available. They know the space and deliver to a high level.

Chambers USA

Profile

Education

Admissions

Axinn's team is always responsive and available. They know the space and deliver to a high level.

Chambers USA

Axinn's team is always responsive and available. They know the space and deliver to a high level.

Chambers USA

News & Insights

View all Insights

July 30, 2024

FDA Expands Practice of Permitting Population-Based Skinny Label “Carve-Ins”

FDA recently doubled down on its approach of allowing new language in an ANDA label as the result of a section viii statement – a...

Axinn Viewpoints

Intellectual Property

July 18, 2024

Axinn Attorneys Appointed to the Executive Committee of the Connecticut Bar Association's Intellectual Property

Axinn is proud to announce that counsel Rebecca Clegg has been appointed Co-Chair of the Connecticut Bar Association's Intellectual Property Section and associate Aaron Savit has been appointed Secretary. The Intellectual Property Section focuses on patent, trademark, copyright, trade secret, unfair competition, and other technology-related areas of the law. Our Axinn representatives will be helping plan the strategy for the section, advocate and lobby for section interests, and promote diversity, equity, and inclusion within the section.

Awards & Recognitions

Intellectual Property

July 11, 2024

Federal Circuit Provides Useful Guidance on Skinny Label Claims

When the Federal Circuit resurrected Amarin’s “skinny label” infringement claims against Hikma last month, it offered some important...

Axinn Viewpoints

Intellectual Property

March 5, 2024

FDA After Chevron

Under the Supreme Court's Chevron doctrine, courts will defer to a federal agency's interpretation of an ambiguous statute unless that interpretation is unreasonable. Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U. S. 837 (1984). In recent years, however, the Supreme Court has hinted at a shift away from Chevron. Several recent cases addressing agency interpretations have ignored Chevron entirely. See, e.g., American Hosp. Ass'n. v. Becerra, 142 S. Ct. 1896 (2022). And, in January of 2024, the Supreme Court heard two cases challenging Chevron’s viability, raising expectations that the doctrine will be overturned or significantly curtailed. See Loper Bright Enters. v. Raimondo, No. 22-451 (U.S.); Relentless, Inc. v. Dep't of Commerce, No. 22-1219 (U.S.).

Byline Articles

Intellectual Property

June 28, 2023

Axinn IP Update: District of Delaware Magistrate Judge Recommends Dismissal of Claims of Induced Infringement in Skinny Label Case

In the first decision to issue following the Supreme Court’s denial of certiorari in Teva Pharms. USA, Inc. v. GlaxoSmithKline, LLC, 22-37, Magistrate Judge Sherry R. Fallon of the United States District Court for the District of Delaware recommended that a complaint be dismissed, which asserted induced infringement of method claims directed to a use carved out of the ANDA product’s label. Zogenix, Inc. v. Apotex Inc., C.A. Nos. 21-1252-RGA, 22-1232-RGA, slip op. (D. Del. June 16, 2023). The decision highlights “[t]he narrow scope of the Federal Circuit’s holding in GlaxoSmithKline” and signals that infringement claims against some ANDA product labels with a section viii carveout may be resolved via a Rule 12 motion.

Publications

Intellectual Property

News & Insights

Related People

Rebecca L. Clegg

Counsel

Rebecca Clegg's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

Learn more

Matthew J. Becker

Intellectual Property Practice Chair

Matt Becker is the Chair of the Intellectual Property practice and has over 25 years of experience trying and litigating a diverse range of patent infringement and trade secret cases. He has tried numerous high-stakes cases to both courts and juries.

Learn more

Ted Mathias

Partner

Ted Mathias serves as lead counsel in complex patent litigation, often managing cases involving more than 15 patents. He frequently handles matters at the intersection of patent and antitrust law, with a strong focus on advising clients in the pharmaceutical industry.

Learn more

Matthew S. Murphy

Partner

Matt Murphy leverages his prior experience as a research scientist to represent pharmaceutical, life sciences, and other companies in complex patent and trade secret litigation.

Learn more